Skip to Main Content

Paper Details

Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.
Int J Radiat Oncol Biol Phys
4
2023
Cancer, Cetuximab, Cisplatin, Locoregionally Advanced Head and Neck, cetuximab, cisplatin, locoregionally advanced head and neck carcinoma, p16, p16-negative oropharynx, patient, patients
Author NameAffiliation
David I RosenthalMD Anderson Cancer Center
Eric J ShermanMemorial Sloan Kettering Cancer Center
Adel K El-NaggarMD Anderson Cancer Center
Adel K El-NaggarMD Anderson Cancer Center
Andre KonskiChester County Hospital/University of Pennsylvania
  • 1 - 5

Datasets

Release 1.2